Healthcare

Healthcare has always required a multi-disciplinary approach encompassing expertise in life sciences, pharmaceuticals, medical devices, materials, electronics, software and more.

With more than 200 attorneys covering every technology as well as lawyers dealing with life cycle commercial agreements, HGF is ideally placed to offer the best combination of industry-specific expertise for any client in the healthcare sector. HGF represents the full spectrum of healthcare clients from global pharmaceutical companies to SMEs and start-ups.

This cross-disciplinary approach is more important than ever with the adoption of AI and other digital technologies into all aspects of healthcare innovation. With developments in personalised medicine, use of AI, big data, robotics, VR, new drug delivery systems and CRISPR technology as well as global healthcare challenges requiring rapid and collaborative response, HGF’s large multidisciplinary teams are the ideal support in this rapidly evolving and complex sector.

Find a specialist
MRI scan
Lab technician

Our healthcare specialists

We’ve built our business by recruiting and developing specialists, not generalists. When it comes to protecting your ideas and business, you want to know you’re working with the best – people who truly understand your sector and the potential of your IP.

HGF’s team has healthcare professionals from an array of academic and business backgrounds. Our team-based approach ensures our clients benefit from the very best strategic advice from people who understand not only the legal environment but also the practical side of your business.

Let's talk

If you would like to discuss how HGF could help you, contact one of our healthcare specialists.

Contact us

Latest news

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article
See all updates